PARP inhibitor monotherapy

Dr Elena Castro on PARPi in CR Prostate Cancer :Day2 #PROSCA24Подробнее

Opportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?Подробнее

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

PARP Inhibitors in the Management of Ovarian Cancer GuidelineПодробнее

11 Apr 2024 - PARP Inhibitors - IOFПодробнее

PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation UpdateПодробнее

M1 CRPC: PARP Inhibitors, Microsatellite Instability  and Precision MedicineПодробнее

Emerging Radiopharmaceuticals and PARP Inhibitors in Prostate Cancer TreatmentПодробнее

Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ov...Подробнее

Ovarian Cancer and Tumor Treating Fields | Oncology Today with Dr Neil Love — Role of PARP Inhibi...Подробнее

M2 - Evolving landscape of PARP inhibitors in mCRPC: combination with anti-androgensПодробнее

Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor...Подробнее

PARPi: Management of Adverse Events (2024)Подробнее

The Evolving Role of PARP & ADCs in Ovarcoming Ovarian CancerПодробнее

PARPi: Precision Medicine in Advanced Prostate Cancer (2023)Подробнее

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combination...Подробнее

What’s New in Prostate Cancer, RCC, and mUC at GU24Подробнее

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combination...Подробнее

M1 - PARP inhibitors as monotherapy in advanced prostate cancerПодробнее